CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase I Trial of Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05389423
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:41:25.517202+00:00
- Published At
- 2026-04-27T00:00:00+00:00
- Record Updated At
- 2026-04-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Diffuse Large Cell Lymphoma", "Non-Hodgkin Lymphoma", "Burkitt Lymphoma", "Plasmablastic Lymphoma", "B-Cell Neoplasm"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-27"- protocolSection.identificationModule.nctId
"NCT05389423"- protocolSection.identificationModule.officialTitle
"Phase I Trial of Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.